Moderna, Inc. — Director's Dealing 2026

Feb 25, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2026-02-23

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-23	Common Stock	M	111679	$19.15	Acquired	1569106	Direct
2026-02-23	Common Stock	M	48330	$19.15	Acquired	1617436	Direct
2026-02-23	Common Stock	S	160009	$48.84	Disposed	1457427	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-23	Stock Option (Right to Buy)	$19.15	M	111679	Disposed	2026-08-10	Common Stock (111679)	Direct
2026-02-23	Stock Option (Right to Buy)	$19.15	M	48330	Disposed	2026-08-10	Common Stock (48330)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect
Common Stock	151933	Indirect

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025.

F2: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

F3: This option is fully vested and exercisable.